Host HLA B allele-associated multi-clade gag T-cell recognition correlates with slow HIV-1 disease progression in antiretroviral theraphy-naïve Ugandans

PLoS ONE

Volumn 4, Issue 1, 2009, Pages

  Serwanga, Jennifer ^a   Shafer, Leigh Anne ^a   Pimego, Edward ^a   Auma, Betty ^a   Watera, Christine ^a   Rowland, Samantha ^b   Yirrell, David ^c   Pala, Pietro ^a   Grosskurth, Heiner ^a   Whitworth, Jimmy ^a   Gotch, Frances ^b   Kaleebu, Potiano ^a  

^a UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^c NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; GAMMA INTERFERON; HLA B ANTIGEN;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CLADISTICS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HLA TYPING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; IMMUNOGENETICS; MALE; UGANDA; VIRUS LOAD; ALLELE; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; PATHOLOGY; T LYMPHOCYTE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ALLELES; CD4-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV INFECTIONS; HLA-B ANTIGENS; HUMANS; INTERFERON-GAMMA; T-LYMPHOCYTES; UGANDA; VIRAL LOAD;

EID: 58449120009     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004188     Document Type: Article

References (64)

1. Patke DS, Langan SJ, Carruth LM, Keating SM, Sabundayo BP, et al. (2002) Association of Gag-specific T lymphocyte responses during the early phase of human immunodeficiency virus type 1 infection and lower virus load set point. J Infect Dis 186(8): 1177-1180.
2. Geldmacher C, Currier JR, Herrmann E, Haule A, Kuta E, et al. (2007) CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients. J Virol 81(5): 2440-2448.
3. Foxall RB, Cortesao CS, Albuquerque AS, Soares RS, Victorino RM, et al. (2008) Gag-specific CD4+ T-cell frequency is inversely correlated with proviral load and directly correlated with immune activation in infection with human immunodeficiency virus type 2 (HIV-2) but not HIV-1. J Virol 82(19): 9795-9799.
4. Novitsky V, Gilbert P, Peter T, McLane MF, Gaolekwe S, et al. (2003) Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection. J Virol 77(2): 882-890.
5. Addo MM, Yu XG, Rathod A, Cohen D, Eldridge RL, et al. (2003) Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol 77(3): 2081-2092.
6. Ostrowski MA, Gu JX, Kovacs C, Freedman J, Luscher MA, et al. (2001) Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses. J Infect Dis 184(10): 1268-1278.
7. Betts MR, Ambrozak DR, Douek DC, Bonhoeffer S, Brenchley JM, et al. (2001) Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection. J Virol 75(24): 11983-11991.
8. Peretz Y, Alter G, Boisvert MP, Hatzakis G, Tsoukas CM, et al. (2005) Human immunodeficiency virus (HIV)-specific gamma interferon secretion directed against all expressed HIV genes: relationship to rate of CD4 decline. J Virol 79(8): 4908-4917.
9. Peretz Y, Tsoukas CM, Bernard NF (2008) HIV Gag-specific immune responses predict the rate of CD4 decline. AIDS 22(10): 1222-1224.
10. Frahm N, Kiepiela P, Adams S, Linde CH, Hewitt HS, et al. (2006) Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes. Nat Immunol 7(2): 173-178.
11. Kiepiela P, Ngumbela K, Thobakgale C, Ramduth D, Honeyborne I, et al. (2007) CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 13(1): 46-53.
12. Novitsky VA, Gilbert PB, Shea K, McLane MF, Rybak N, et al. (2006) Interactive association of proviral load and IFN-gamma-secreting T cell responses in HIV-1C infection. Virology 349(1): 142-155.
13. Jiao Y, Xie J, Li T, Han Y, Qiu Z, et al. (2006) Correlation between gag-specific CD8 T-cell responses, viral load, and CD4 count in HIV-1 infection is dependent on disease status. J Acquir Immune Defic Syndr 42(3): 263-268.
14. Wang B, Dyer WB, Zaunders JJ, Mikhail M, Sullivan JS, et al. (2002) Comprehensive analyses of a unique HIV-1-infected nonprogressor reveal a complex association of immunobiological mechanisms in the context of replication-incompetent infection. Virology 304(2): 246-264.
15. Troyer RM, Collins KR, Abraha A, Fraundorf E, Moore DM, et al. (2005) Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression. J Virol 79(14): 9006-9018.
16. Navis M, Schellens I, van Baarle D, Borghans J, van Swieten P, et al. (2007) Viral replication capacity as a correlate of HLA B57/ B5801-associated nonprogressive HIV-1 infection. J Immunol 179(5): 3133-3143.
17. Kaleebu P, French N, Mahe C, Yirrell D, Watera C, et al. (2002) Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis 185(9): 1244-1250.
18. Kiwanuka N, Laeyendecker O, Robb M, Kigozi G, Arroyo M, et al. (2008) Effect of Human Immunodeficiency Virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. J Infect Dis 197(5): 707-713.
19. Honeyborne I, Prendergast A, Pereyra F, Leslie A, Crawford H, et al. (2007) Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8+ T-cell epitopes. J Virol 81(7): 3667-3672.
20. Bratt G, Leandersson AC, Albert J, Sandström E, Wahren B (1998) MT-2 tropism and CCR-5 genotype strongly influence disease progression in HIV-1-infected individuals. AIDS 12(7): 729-736.
21. Goulder PJ, Watkins DI (2008) Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat Rev Immunol 8(8): 619-630.
22. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, et al. (2007) A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1. Science 317(5840): 944-947.
23. Choudhary SK, Vrisekoop N, Jansen CA, Otto SA, Schuitemaker H, et al. (2007) Low immune activation despite high levels of pathogenic human immunodeficiency virus type 1 results in long-term asymptomatic disease. J Virol 81(16): 8838-8842.
24. O'Brien SJ, Gao X, Carrington M (2001) HLA and AIDS: a cautionary tale. Trends Mol Med 7(9): 379-381.
25. Betts MR, Exley B, Price DA, Bansal A, Camacho ZT, et al. (2005) Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection. Proc Natl Acad Sci USA 102(12): 4512-4517.
26. Sekaly RP (2008) The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? J Exp Med 205(1): 7-12.
27. Cozzi Lepri A, Sabin CA, Phillips AN, Lee CA, Pezzotti P, et al. (1998) The rate of CD4 decline as a determinant of progression to AIDS independent of the most recent CD4 count. The Italian Seroconversion Study. Epidemiol Infect 121(2): 369-376.
28. Lyles RH, Muñoz A, Yamashita TE, Bazmi H, Detels R, et al. (2000) Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. J Infect Dis 181(3): 872-880.
29. Frahm N, Kaufmann DE, Yusim K, Muldoon M, Kesmir C, et al. (2007) Increased sequence diversity coverage improves detection of HIV-specific T cell responses. J Immunol 179(10): 6638-6650.
30. Tsegaye A, Ran L, Wolday D, Petros B, Nanlohy NM, et al. (2007) Stable pattern of HIV-1 subtype C Gag-specific T-cell responses coincides with slow rate of CD4 T-cell decline in HIV-infected Ethiopians. AIDS 21(3): 369-372.
31. Brumme ZL, Tao I, Szeto S, Brumme CJ, Carlson JM, et al. (2008) Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection. AIDS 22(11): 1277-1286.
32. Pantaleo G, Koup RA (2004) Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know. Nat Med 10(8): 806-810.
33. Rutebemberwa A, Auma B, Gilmour J, Jones G, Yirrell D, et al. (2004) HIV type 1-specific inter- and intrasubtype cellular immune responses in HIV type 1-infected Ugandans. AIDS Res Hum Retroviruses 20(7): 763-771.
34. McKinnon LR, Ball TB, Kimani J, Wachihi C, Matu L, et al. (2005) Cross-clade CD8(+) T-cell responses with a preference for the predominant circulating clade. J Acquir Immune Defic Syndr 40(3): 245-249.
35. Coplan PM, Gupta SB, Dubey SA, Pitisuttithum P, Nikas A, et al. (2005) Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents. J Infect Dis 191(9): 1427-1434.
36. Barugahare B, Baker C, K'Aluoch O, Donovan R, Elrefaei M, et al. (2005) Human immunodeficiency virus-specific responses in adult Ugandans: patterns of cross-clade recognition. J Virol 79(7): 4132-4139.
37. Gupta SB, Mast CT, Wolfe ND, Novitsky V, Dubey SA, et al. (2006) Cross-clade reactivity of HIV-1-specific T-cell responses in HIV-1-infected individuals from Botswana and Cameroon. J Acquir Immune Defic Syndr 42(2): 135-139.
38. McAdam S, Kaleebu P, Krausa P, Goulder P, French N, et al. (1998) Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection. AIDS 12(6): 571-579.
39. Bennett MS, Ng HL, Ali A, Yang OO (2008) Cross-clade detection of HIV-1-specific cytotoxic T lymphocytes does not reflect cross-clade antiviral activity. J Infect Dis 197(3): 390-397.
40. Valentine LE, Piaskowski SM, Rakasz EG, Henry NL, Wilson NA, et al. (2008) Recognition of escape variants in ELISPOT does not always predict CD8+ T-cell recognition of simian immunodeficiency virus-infected cells expressing the same variant sequences. J Virol 82(1): 575-581.
41. Streeck H, Li B, Poon AF, Schneidewind A, Gladden AD, et al. (2008) Immune-driven recombination and loss of control after HIV superinfection. J Exp Med 205(8): Epub.
42. Frahm N, Kaufmann DE, Yusim K, Muldoon M, Kesmir C, et al. (2007) Increased sequence diversity coverage improves detection of HIV-specific T cell responses. J Immunol 179(10): 6638-6650.
43. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, et al. (2006) HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107(12): 4781-4789.
44. Ferrari G, Liu M, Marking C, Goonetilleke N, Betts M, et al. (2008) Lack of Highly Poly-Functional Epitope-Specific CD8+ Memory T Cell Responses during Spontaneous Control of Viremia. AIDS Research and Human Retroviruses 24(s1): 20. Abstract OA06-04.
45. López M, Soriano V, Lozano S, Ballesteros C, Cascajero A, et al. (2008) No major differences in the functional profile of HIV Gag and Nef-specific CD8+ responses between long-term nonprogressors and typical progressors. AIDS Res Hum Retroviruses 24(29): 1185-1195. Links.
46. Schellens IM, Borghans JA, Jansen CA, De Cuyper IM, Geskus RB, et al. (2008) Abundance of early functional HIV-specific CD8+ T cells does not predict AIDS-free survival time. PLoS ONE 3(7): e2745.
47. Maness NJ, Yant LJ, Chung C, Loffredo JT, Friedrich TC, et al. (2008) Comprehensive immunological evaluation reveals surprisingly few differences between elite controller and progressor Mamu-B*17-positive Simian immunodeficiency virus-infected rhesus macaques. J Virol 82(11): 5245-5254.
48. Frahm N, Adams S, Kiepiela P, Linde CH, Hewitt HS, et al. (2005) HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load. J Virol 79(16): 10218-10225.
49. Emu B, Sinclair E, Hatano H, Ferre A, Shacklett B, et al. (2008) HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control. J Virol 82(11): 5398-5407.
50. Chopera DR, Woodman Z, Mlisana K, Mlotshwa M, Martin DP, et al. (2008) Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage. PLoS Pathog 4(3): e1000033.
51. Frater AJ, Brown H, Oxenius A, Günthard HF, Hirschel B, et al. (2007) Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression. J Virol 81(12): 6742-6751.
52. Ngumbela KC, Day CL, Mncube Z, Nair K, Ramduth D, et al. (2008) Targeting of a CD8 T cell env epitope presented by HLA-B*5802 is associated with markers of HIV disease progression and lack of selection pressure. AIDS Res Hum Retroviruses 24(1): 72-82.
53. Lazaryan A, Lobashevsky E, Mulenga J, Karita E, Allen S, et al. (2006) Human leukocyte antigen B58 supertype and human immunodeficiency virus type 1 infection in native Africans. J Virol 80(12): 6056-6060.
54. Schneidewind A, Brockman MA, Yang R, Adam RI, Li B, et al. (2007) Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. J Virol 81(22): 12382-12393.
55. Matthews PC, Prendergast A, Leslie A, Crawford H, Payne R, et al. (2008) Central role of reverting mutations in HLA associations with human immunodeficiency virus set point. 3: J Virol 82(17): 8548-8559.
56. Crawford H, Prado JG, Leslie A, Hué S, Honeyborne I, et al. (2007) Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection. J Virol 81(15): 8346-8351.
57. Leslie AJ, Pfafferott KJ, Chetty P, Draenert R, Addo MM, et al. (2004) HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 10(3): 282-289.
58. van Benthem BH, Vernazza P, Coutinho RA, Prins M, European Study on the Natural History of HIV Infection in Women and the Swiss HIV Cohort Study (2002) The impact of pregnancy and menopause on CD4 lymphocyte counts in HIV-infected women. AIDS 16(6): 919-924.
59. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, et al. (1987) The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 126(2): 310-318.
60. Argüello JR, Little AM, Bohan E, Goldman JM, Marsh SG, et al. (1998) High resolution HLA class I typing by reference strand mediated conformation analysis (RSCA). Tissue Antigens 52(1): 57-66.
61. Yirrell DL, Shaw L, Campbell E, Burns SM, Cameron SO, et al. (2007) HIV subtypes in Scotland, 2000-2006. Epidemiol Infect 9: 1-7.
62. Van de Peer Y, De Wachter R (1994) TREECON for Windows: a software package for the construction and drawing of evolutionary trees for the Microsoft Windows environment. Comput Applic Biosci 10: 569-570.
63. Yirrell DL, Kaleebu P, Morgan D, Watera C, Magambo B, et al. (2002) Inter and intra-genic inter-subtype HIV-1 recombination in rural and semi-urban Uganda. AIDS 16: 279-286.
64. Kebba A, Kaleebu P, Serwanga J, Rowland S, Yirrell D, et al. (2004) HIV type 1 antigen-responsive CD4+ T-lymphocytes in exposed yet HIV Type 1 seronegative Ugandans. AIDS Res Hum Retroviruses 20(1): 67-75.